Franchising since 2021 · 7 locations
The total investment to open a MDH Franchisor LLC MD Hyperbaric franchise ranges from $129,550 - $524,200. The initial franchise fee is $50,000. Ongoing royalties are 8% plus a 2% advertising fee. MDH Franchisor LLC MD Hyperbaric currently operates 7 locations. Data sourced from the 2023 Franchise Disclosure Document.
$129,550 - $524,200
$50,000
7
This franchise has not yet been scored by the Franchise Performance Index. Scores are calculated based on public FDD data, SBA loan performance, and system-level metrics.
MDH Franchisor LLC, operating as MD Hyperbaric, represents a pioneering force in the burgeoning hyperbaric oxygen therapy (HBOT) market, having been founded in 2021 by Dr. Martin O'Malley, a world-renowned orthopedic surgeon. Dr. O'Malley brings an unparalleled medical pedigree to the Mdh Franchisor Llc Md Hyperbaric franchise, being a Board Certified Orthopedic Surgeon, a UHMS Certified Hyperbaric Practitioner, and having served as a team physician for the Brooklyn Nets, a distinguished foot and ankle consultant for the New York Giants and New Jersey Devils, and former team physician for both USA Basketball and The New York Knicks. This robust medical foundation is complemented by the formidable business acumen of co-founder and Board Member Mark Wiseman, a former Top Executive at BlackRock, where he oversaw trillions in investments, and previously the President & CEO of the Canada Pension Plan Investment Board (CPPIB). At the helm as CEO is Chris Neal, who previously served as the Head of Operations for Restore Hyper Wellness, a rapidly expanding wellness company with over 250 locations, and has a track record of leading complex projects for major corporations such as Comcast, Vanguard Financial, and Penn Medical Health System. The company's strategic vision is to provide a medically-supervised approach to HBOT, ensuring a clinically excellent and patient-centric experience that aims to democratize this impactful therapy with a consistent, credible operation. MDH Franchisor LLC, the entity offering the Mdh Franchisor Llc Md Hyperbaric franchise, was specifically formed in late 2023 as a wholly-owned subsidiary of its parent company, MD Hyperbaric Holding Inc., and commenced its franchising operations in 2024. While one source indicates the corporate headquarters is located in New York, NY, specifically at 360 E. 72nd Street, New York, NY 10021, another source identifies West Orange, New Jersey, as the Corporate HQ. The Mdh Franchisor Llc Md Hyperbaric franchise leverages FDA-cleared, NFPA- and ASME-compliant technology, specifically the Fortius 420 chambers from Oxyhealth, which are engineered to deliver true HBOT with 100% oxygen at pressures up to 3 ATA, underscoring its commitment to medical-grade standards.
The hyperbaric oxygen therapy (HBOT) market is currently experiencing significant expansion, characterized as a booming wellness market and a rapidly growing space. The global market for Hyperbaric Oxygen Therapy was valued at $2.4 billion in 2020 and is projected to achieve a robust Compound Annual Growth Rate (CAGR) of 7.2% from 2020 through 2028, indicating substantial growth potential for the Mdh Franchisor Llc Md Hyperbaric franchise. This burgeoning market is driven by surging consumer demand for non-invasive wellness treatments and the increasing validation of HBOT's benefits across diverse medical applications. These applications extend to neurological conditions, post-surgical recovery, comprehensive wound care, and sports medicine, while also addressing conditions such as Long COVID, general wellness, and autoimmune disorders. A significant portion of patients, specifically 51%, seek HBOT for wound and post-surgical treatments, which prominently include orthopedic and plastic surgeries, highlighting a key patient demographic. Furthermore, HBOT is recognized as a critical modality for athletes aiming to accelerate their return to sport, benefiting from its clinically validated and trusted application in elite sports and hospital systems. The industry landscape for HBOT remains highly fragmented, lacking a dominant brand that offers standardized medical-grade treatments underpinned by extensive clinical expertise. The Mdh Franchisor Llc Md Hyperbaric franchise is strategically positioned to address this market gap by providing a consistent and credible operational framework, operating precisely at the intersection of traditional medicine and proactive wellness. This unique positioning allows the Mdh Franchisor Llc Md Hyperbaric franchise to tap into multiple billion-dollar markets, further solidifying its promising market position.
Investing in a Mdh Franchisor Llc Md Hyperbaric franchise involves a clear financial commitment, with specific figures outlined for prospective franchisees. The initial franchise fee for the Mdh Franchisor Llc Md Hyperbaric franchise is reported as $50,000, although another source indicates $75,000. For clarity and consistency, the figure of $50,000 is often cited as the one-time fee. The total investment range for establishing a Mdh Franchisor Llc Md Hyperbaric franchise shows some variation across sources, reflecting different models and build-out requirements. According to FDD Item 7, the total investment range is $129,550 to $524,200. Other sources provide broader estimates, such as $300,000 to $500,000, inclusive of equipment, build-out, and initial inventory, or $200,000 to $500,000 depending on the chosen center model. Further figures include $333,550 to $549,200, and $208,635 to $338,076. These figures encompass essential startup costs such as equipment acquisition, necessary build-out expenses, and initial inventory to commence operations. The ongoing royalty rate for the Mdh Franchisor Llc Md Hyperbaric franchise is typically 8% of gross sales, representing a recurring fee for continuous support and brand usage, though another source mentions 10% of monthly gross revenue as a Royalty/Brand Fee. Additionally, a marketing fee, or Ad Fund contribution, of 2% of gross sales is required, allocated towards national and regional marketing initiatives to bolster brand visibility and patient acquisition efforts. Prospective franchisees are also required to meet a minimum cash requirement, or liquid capital, which ranges from $50,000 to a higher-end figure, influenced by the chosen location, specific build-out costs, and the particular center model selected. Financing options are available for qualified candidates, including equipment financing through their HBOT chamber partner and comprehensive project financing via SBA loans. The business model is designed for rapid revenue generation, with franchisees typically beginning to generate revenue in their first month of business, and an expected payback period ranging from 12 to 18 months, highlighting the robust economic potential of the Mdh Franchisor Llc Md Hyperbaric franchise.
The operating model and support structure for the Mdh Franchisor Llc Md Hyperbaric franchise are designed to be comprehensive, ensuring franchisees are well-equipped to deliver high-quality hyperbaric oxygen therapy. The company employs a three-tiered franchise model to accommodate a broad market fit and various investment levels. The first tier, "Start-Up," is tailored for integrating HBOT directly into existing physician practices, typically involving 1 to 2 hyperbaric chambers within a compact 100-150 square foot space with minimal construction requirements. The second tier, "Integration," focuses on creating dedicated branded spaces within existing medical offices, necessitating the renovation of more than 150 square feet to house 2 to 3 chambers. The most extensive option, the "Flagship" model, involves establishing standalone centers that serve as recovery pillars in their communities, often accommodating three to four or more chambers within a dedicated 650 to 1,100 square foot center, typically situated within a medical office building or a retail space. MD Hyperbaric offers extensive development support, encompassing crucial stages such as site selection, lease negotiation, detailed design, and efficient build-out processes. Training is robust and multi-faceted, covering staff hiring, comprehensive onboarding, operational protocols, and performance monitoring. This includes industry-standard certification for medical directors, MD Hyperbaric-specific operational training, and tech platform training that integrates CRM and HR tools. Furthermore, industry-recognized training in Hyperbaric Medicine is provided to ensure all personnel are highly competent. Ongoing operational support is a cornerstone of the Mdh Franchisor Llc Md Hyperbaric franchise, with the team providing continuous guidance through a detailed operations playbook, medical protocols meticulously written by medical directors, and robust compliance systems. Post-launch, franchisees benefit from ongoing marketing support, regular operational reviews, and compliance evaluations. Marketing assistance includes strategic digital campaigns, effective referral programs, and targeted community outreach. Centralized medical oversight is a distinctive feature of the Mdh Franchisor Llc Md Hyperbaric franchise, with each location staffed by prequalified medical directors who have access to an extensive research library and a network-wide best practices repository. These medical directors are responsible for reviewing patient intake forms, treatment plans, and progress, collaborating with referring physicians on treatment protocols, periodically reviewing treatment outcomes and feedback, and advising on complex or unusual patient cases. They must hold an MD, DO, or possess Prescriptive Authority as per State Regulations. The entire Mdh Franchisor Llc Md Hyperbaric franchise system is built as a "turnkey" model, specifically designed to simplify the operational complexities of hyperbaric therapy, enabling lean operations with minimal staff, low overhead, and a compact footprint, all geared towards scale, passive income, and multi-unit expansion.
The financial performance of the Mdh Franchisor Llc Md Hyperbaric franchise is described as impressive, built upon a lean operational model designed for success with strong unit economics and multiple revenue streams. Based on the 2024 Item 19 disclosure within the 2025 FDD, a representative snapshot of annual financial performance indicates Annual Gross Sales of $740,796 and an EBITDA of $263,634. Another source corroborates these figures, suggesting an average annual revenue range of $700,000 to $900,000. These figures underscore the potential for high-margin treatment packages that drive consistent income within the Mdh Franchisor Llc Md Hyperbaric franchise system. The business model emphasizes low overhead and quick startup timelines, making it an attractive proposition for entrepreneurs seeking efficiency and scalability. A significant aspect contributing to the strong financial performance is the high recurrence rate among patients, with 75% returning for multiple HBOT sessions and 42% returning for over 5 consecutive sessions, fostering lasting patient relationships and predictable revenue streams. The average patient volume reported is 64 patients per month, reflecting consistent demand for the therapy. Patient acquisition for the Mdh Franchisor Llc Md Hyperbaric franchise occurs through three primary referral sources. External Referrals account for 40% of patients, originating from a diverse network of medical professionals including plastic surgeons, orthopedic surgeons, oncologists, internalists, and other specialized practitioners. Self-Referrals constitute 37% of patient acquisitions, driven by individuals who discover MD Hyperbaric through digital marketing efforts, word of mouth recommendations, or other awareness campaigns. The remaining 23% of patients are generated through Internal Referrals, primarily from the presiding Medical Director or Partner within the Mdh Franchisor Llc Md Hyperbaric franchise location. This multi-pronged patient acquisition strategy, combined with the high patient retention rates, creates a robust foundation for the financial success of each Mdh Franchisor Llc Md Hyperbaric franchise unit.
The Mdh Franchisor Llc Md Hyperbaric franchise is currently in a very early and rapid growth phase, poised for significant expansion across the United States. The franchisor, MDH Franchisor LLC, was established in late 2023 and officially commenced its franchising operations in 2024. As of the close of 2024, the Mdh Franchisor Llc Md Hyperbaric franchise had one single franchised outlet open. However, momentum has been building swiftly, as an article from May 2025 reported the company had already grown to six operating locations and projected to more than double that number by the end of the year, indicating an aggressive expansion strategy. In its inaugural year of operation, the Mdh Franchisor Llc Md Hyperbaric franchise successfully signed seven new franchise agreements, demonstrating strong initial interest and market acceptance. The company’s ambition is to expand nationwide, a plan clearly articulated by its franchise inquiry form which lists all 50 U.S. states as potential territories, signaling a comprehensive national expansion blueprint. Furthermore, MD Hyperbaric has strategically mapped out its top ten expansion markets across the U.S., focusing its efforts on identifying and partnering with the right individuals to drive this growth. There is no publicly available information regarding the Mdh Franchisor Llc Md Hyperbaric franchise’s operations or expansion plans in other countries, suggesting a primary focus on the domestic market at this time. The company’s competitive advantages are rooted in its medically-supervised approach, ensuring clinically excellent and patient-centric care. It aims to fill a void in the fragmented HBOT market by offering standardized medical-grade treatments backed by robust clinical expertise. The use of FDA-cleared, NFPA- and ASME-compliant Fortius 420 chambers from Oxyhealth, delivering 100% oxygen at up to 3 ATA, underscores its commitment to safety and efficacy. The comprehensive support structure, from site selection to ongoing marketing, coupled with a turnkey operational model, positions the Mdh Franchisor Llc Md Hyperbaric franchise for sustained growth. The objective is to make medical-grade hyperbaric therapy widely accessible to communities everywhere, leveraging strong unit economics and multiple revenue streams to achieve this ambitious goal.
The ideal franchisee for the Mdh Franchisor Llc Md Hyperbaric franchise is an individual or group seeking to enter the rapidly expanding hyperbaric oxygen therapy market with a medically-supervised and clinically excellent approach. The company emphasizes finding the "right partners," suggesting a preference for individuals who possess not only the financial capacity but also an understanding of, or a strong interest in, the healthcare and wellness sector. Prospective franchisees should be prepared to meet the investment requirements, including a liquid capital of at least $50,000 within the overall investment range of $129,550 to $524,200. An entrepreneurial mindset, coupled with a desire for a lean operational model and an interest in multi-unit expansion, aligns well with the Mdh Franchisor Llc Md Hyperbaric franchise's growth strategy. Franchisees will benefit from a business model designed for recurring revenue, supported by a high percentage of patients returning for multiple sessions, with 75% returning for various treatments and 42% continuing for over 5 consecutive sessions. The Mdh Franchisor Llc Md Hyperbaric franchise offers a flexible territory approach through its three-tiered model, allowing for broad market fit. This ranges from integrating HBOT into existing physician practices within a compact 100-150 square foot space, to establishing standalone flagship centers occupying 650-1,100 square feet. The national expansion plan, clearly indicated by the listing of all 50 U.S. states on the franchise inquiry form and the identification of top ten expansion markets, provides ample territory options for qualified candidates. Franchisees are expected to oversee the operational aspects of their center, including managing the prequalified medical directors who are an integral part of the Mdh Franchisor Llc Md Hyperbaric franchise's commitment to medical oversight and patient care.
The Mdh Franchisor Llc Md Hyperbaric franchise presents a compelling investor opportunity within a booming wellness market, valued at $2.4 billion in 2020 and projected to grow at a Compound Annual Growth Rate of 7.2% through 2028. This represents an early-stage growth opportunity, with the franchise system having only commenced operations in 2024 and expanding from one franchised outlet at the end of 2024 to six operating locations by May 2025, with plans to double that number by year-end. The Mdh Franchisor Llc Md Hyperbaric franchise has secured 7 franchise agreements in its inaugural year, signaling strong market entry. Unit economics are robust, as evidenced by the 2024 Item 19 disclosure from the 2025 FDD, reporting Annual Gross Sales of $740,796 and an EBITDA of $263,634. The business model emphasizes low overhead, quick startup timelines, and is built for scale, facilitating passive income and multi-unit expansion. While the Mdh Franchisor Llc Md Hyperbaric franchise offers significant upside, it is important for potential investors to consider insights from the FDD analysis. The audited 2024 financial statements for MDH Franchisor LLC indicate a net loss of over $57,000 and a negative net worth (Member's Deficit) of over $47,000, suggesting some franchisor financial instability in its early stages. Furthermore, the Mdh Franchisor Llc Md Hyperbaric franchise is a new and unproven system in the franchise context, with a short operating history. The FDD does not include financial statements for the parent company, MD Hyperbaric Holding Inc., nor does it state that the parent guarantees the franchisor's obligations, which makes a comprehensive assessment of overall financial strength challenging. Additionally, while management possesses extensive experience in their respective fields, their direct experience in managing or operating a franchise system appears limited at the executive franchising leadership level. The rapid growth phase of the Mdh Franchisor Llc Md Hyperbaric franchise, with seven agreements signed but only one unit open as of late 2024, could potentially strain resources, impacting support systems and quality control. Despite these identified risks, the strong unit economics, high patient recurrence rates, and the company's strategic positioning within a high-growth market make the Mdh Franchisor Llc Md Hyperbaric franchise a potentially lucrative investment for the right partner seeking to capitalize on the increasing demand for medical-grade hyperbaric therapy. Explore the complete Mdh Franchisor Llc Md Hyperbaric franchise profile on PeerSense to access the full suite of independent franchise intelligence data.
Key performance metrics for MDH Franchisor LLC MD Hyperbaric based on SBA lending data
Investment Tier
Significant investment
$129,550 – $524,200 total
Estimated Monthly Payment
$1,341
Principal & Interest only
MDH Franchisor LLC MD Hyperbaric — unit breakdown
Our business financing consultants help connect you with the right lending partners. No retainers — referral fee paid at closing.
Or get an instant analysis
Scan Your Deal InstantlyReview franchise fees, investment ranges, royalties, Item 19 financial data, and year-over-year trends. Request complimentary access through your PeerSense funding advisor.